Cardiff-by-the-Sea, CA, United States of America

Corey Gutierrez

This inventor holds 5 USPTO granted patents. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2009-2011.


% Patents Active = 80.0

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • San Diego, CA (US) (2010)
  • Cardiff-by-the-Sea, CA (US) (2009 - 2011)

Company Filing History:


Years Active: 2009-2011

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Corey Gutierrez: Innovator in Calcium Channel Modulation

Introduction

Corey Gutierrez is a notable inventor based in Cardiff-by-the-Sea, CA. He has made significant contributions to the field of pharmacology, particularly in the modulation of calcium channels. With a total of 5 patents to his name, Gutierrez is recognized for his innovative approaches to treating various medical conditions.

Latest Patents

Among his latest patents, Gutierrez has developed heterocyclic derivatives that act as calcium channel antagonists. These compositions are particularly useful for treating or relieving conditions mediated by calcium channels. Additionally, he has created sulfonamide derivatives that serve as ion channel antagonists, which are beneficial in treating pain-related conditions.

Career Highlights

Corey Gutierrez is currently employed at Vertex Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work focuses on creating effective therapeutic solutions that address critical health issues.

Collaborations

Throughout his career, Gutierrez has collaborated with esteemed colleagues, including Andreas Peter Termin and Esther Martinborough, who contribute to his innovative projects.

Conclusion

Corey Gutierrez exemplifies the spirit of innovation in the pharmaceutical industry. His work in calcium channel modulation and pain management showcases the potential of his inventions to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…